| Author | No. of cases | Age, yr (median) | Androgen deprivation therapy | Response |
|---|---|---|---|---|
| Locati et al. (6) | 7 | 68 | Bicalutamide + LHRH analogue | 1 CR 2 PR 1 SD |
| Jaspers et al. (5) | 10 | 66 | 9 bicalutamide, 1 bicalutamide + LHRH analogue | 2 PR 3 SD 5 PD |
| Soper et al. (3) | 1 | 87 | Bicalutamide + LHRH analogue + RT | CR |
| Yamamoto et al. (11) | 1 | 66 | Bicalutamide | CR |
| Agbarya et al. (1) | 1 | 57 | Bicalutamide | CR |
| Urban et al. (4) | 1 | 45 | Abiraterone, prednisone and LHRH analogue | CR |
| Our patient (Box 1) | 1 | 72 | Bicalutamide + LHRH analogue | PR |
Note: CR = complete response, LHRH = luteinizing hormone–releasing hormone, PD = progressive disease, PR = partial response, RT = radiation therapy, SD = stable disease.